Novartis AG (NOTA) Stock Price & News

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024. Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others. Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes. After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia

About Novartis AG

CEOVasant Narasimhan

Employees75,3 ພັນ

Founded7 ມ.ນ. 1996

Headquartersບາເຊວ, Basel City, ສະວິດເຊີແລນ

SectorPharmaceutical industry

Websitenovartis.com

Revenue

Net income

All values in USD	ກ.ຍ. 2025	ທ.ວ. 2025	ມ.ນ. 2026	ມິ.ຖ. 2026
Revenue	14,36 ຕື້	13,86 ຕື້	13,52 ຕື້	14,95 ຕື້
Cost of goods sold	3,54 ຕື້	3,54 ຕື້	3,44 ຕື້	3,68 ຕື້
Cost of revenue	3,54 ຕື້	3,54 ຕື້	3,44 ຕື້	3,68 ຕື້
Research and development expenses	2,86 ຕື້	2,84 ຕື້	2,78 ຕື້	2,74 ຕື້
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3,30 ຕື້	3,44 ຕື້	3,14 ຕື້	3,23 ຕື້
Operating expense	6,24 ຕື້	6,46 ຕື້	5,96 ຕື້	6,10 ຕື້
Total operating expenses	9,77 ຕື້	10,00 ຕື້	9,40 ຕື້	9,78 ຕື້
Operating income	4,58 ຕື້	3,86 ຕື້	4,12 ຕື້	5,18 ຕື້
Other non operating income	-7,00 ລ້ານ	-130,00 ລ້ານ	4,00 ລ້ານ	19,00 ລ້ານ
EBT including unusual items	4,20 ຕື້	3,22 ຕື້	3,84 ຕື້	4,27 ຕື້
EBT excluding unusual items	4,29 ຕື້	3,49 ຕື້	3,78 ຕື້	4,73 ຕື້
Income tax expense	266,00 ລ້ານ	814,00 ລ້ານ	683,00 ລ້ານ	1,01 ຕື້
Effective tax rate	6,34%	25,30%	17,79%	23,71%
Other operating expenses	70,00 ລ້ານ	190,00 ລ້ານ	42,00 ລ້ານ	127,00 ລ້ານ
Net income	3,93 ຕື້	2,41 ຕື້	3,16 ຕື້	3,26 ຕື້
Net profit margin	27,36%	17,38%	23,34%	21,83%
Earnings per share	2,25	2,03	1,99	2,41
Interest and investment income	-	373,00 ລ້ານ	-	-
Interest expense	-281,00 ລ້ານ	-304,00 ລ້ານ	-343,00 ລ້ານ	-462,00 ລ້ານ
Net interest expenses	-281,00 ລ້ານ	69,00 ລ້ານ	-343,00 ລ້ານ	-462,00 ລ້ານ
Depreciation and amortization charges	-	-	-	-
EBITDA	5,78 ຕື້	4,96 ຕື້	5,24 ຕື້	6,30 ຕື້
Gain or loss from assets sale	81,00 ລ້ານ	80,00 ລ້ານ	-159,00 ລ້ານ	-247,00 ລ້ານ

Ask anything